businesspress24.com - Intrexon's AgBio Division Expands Its Operations
 

Intrexon's AgBio Division Expands Its Operations

ID: 1025817

(firmenpresse) - DURHAM, NC -- (Marketwire) -- 07/29/11 -- Intrexon Corporation, a next generation company, announced that its Agricultural Biotechnology (AgBio) Division has recently expanded to a new location in Research Triangle Park, North Carolina. The 28,000 square foot facility was recently occupied by Athenix Corporation, a Bayer CropScience company.

"This is a state-of-the-art facility that will allow us to accelerate our plant and mushroom research and development efforts," stated Division President, Matthew Crisp. "It is substantially larger than the space we previously occupied and can accommodate our multi-year growth projections for both our lab and office needs." Crisp also mentioned that as part of the move the division would eventually be taking possession of a greenhouse that is adjacent to the new property.

Intrexon launched its AgBio Division in February of this year and simultaneously announced the acquisition of Agarigen, Inc., a North Carolina-based company that had developed a novel, mushroom-based expression platform for the rapid, high yield production of recombinant proteins. The division was located in the smaller Agarigen facility before making the recent move. "Our staff size has increased significantly in the past six months and we were outgrowing our old space," commented Don Walters, Ph.D., and Vice President of R&D for the division. "We have a number of job openings currently and expect to continue our hiring ramp for the foreseeable future. As Matt stated, the new space gives us ample room for that growth while also providing excellent lab configurations and capabilities for the many plant and mushroom studies we are conducting."

Intrexon Corporation is a privately held synthetic biology company that employs modular DNA control systems to enhance capabilities, improve safety and lower cost in , , , , and . The company's advanced engineering platform enables ™ by combining revolutionary DNA control systems with corresponding advancements in modular transgene design, assembly and optimization. More information about the company is available at .







Andy Udell
Intrexon Corporation
Phone: 301-556-9850
E-mail:


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Functional Technologies Announces Third Quarter 2011 Financial Results
Top Considerations of US Debt Limit -- Equity Research on Endo Pharmaceuticals and Amgen, Inc.
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 29.07.2011 - 05:30 Uhr
Sprache: Deutsch
News-ID 1025817
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

DURHAM, NC


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 385 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Intrexon's AgBio Division Expands Its Operations
"
steht unter der journalistisch-redaktionellen Verantwortung von

Intrexon Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Intrexon Corporation



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 68


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.